Linking beta-catenin to androgen-signaling pathway

Area of Science:

• Molecular Biology
• Cancer Biology
• Cell Signaling

Background:

• The androgen receptor (AR) pathway is crucial for prostate cancer growth and progression.
• AR transcriptional activity is modulated by interactions with cofactors.
• Beta-catenin is involved in cell adhesion and Wnt signaling, with roles in development and cancer.

Purpose of the Study:

• To investigate the potential interaction between beta-catenin and the androgen receptor (AR).
• To determine the functional consequence of beta-catenin and AR interaction in prostate cancer cells.
• To explore the role of E-cadherin in regulating this interaction and AR activity.

Main Methods:

• Co-immunoprecipitation assays to demonstrate protein-protein interaction.
• Site-directed mutagenesis to identify domains involved in AR-beta-catenin interaction.
• Reporter gene assays to assess AR transcriptional activity.
• Cell culture experiments involving E-cadherin expression in prostate cancer cells.

Main Results:

• A specific protein-protein interaction was confirmed between beta-catenin and AR, distinct from interactions with other steroid hormone receptors.
• The ligand-binding domain of AR and the N-terminus/armadillo repeats of beta-catenin are essential for this interaction.
• Beta-catenin enhances ligand-dependent AR activity in prostate cancer cells.
• Loss of E-cadherin leads to increased cytoplasmic beta-catenin and augmented AR-mediated transcription, while E-cadherin re-expression reduces AR activity.

Conclusions:

• Beta-catenin directly interacts with the androgen receptor, augmenting its transcriptional activity in prostate cancer.
• Loss of E-cadherin in prostate cancer cells increases beta-catenin availability, potentially promoting tumor progression by enhancing AR signaling.
• Targeting the beta-catenin-AR interaction could offer a novel therapeutic strategy for prostate cancer.